Medscape covers a study of Reddit comments on the trial drug, where users reported fatigue, insomnia, more appetite and, oddly, more energy.
Recap by typeshit. Post by @Medscape on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
The interim policy, now with OMB, would let pharmacies compound select peptides with less enforcement risk, but without FDA approval.
Todd Engel, 63, says he developed NAION on Ozempic and lost his career as a truck driver. Novo Nordisk calls the suit meritless and says trials show no added risk.
Loading…